MENA Region Landscape
Pharma Business Size*
- Biggest MKT (KSA 28%, EGY 21%,
S.Afr 12% & UAE 9%).
- FWA with fastest growth 16% PPG.
Rare & Orphan Diseases *
- Est. globally there are 5000-8000 orphan disease that have been identified with only 1500 identified includes (Sickle Cell Disease, Thalassemia, Hemophilia, certain inborn errors of metabolism (Pompe’s disease, Mucopolysaccharidosis types) and Bechet’s disease.
- EST. 2.97 Million patients in the MENA region
By 2025, MENA pharma market collectively to be US$ 56 B.
- *IQVIA MENA market report Q1 2022
- *IQVIA Orphan & Rare disease white paper 2019
- *The Center of Arab Genomic Studies (CAGS)